Malalis, Myla .

HRN: 11-66-32  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/12/2025
CEFUROXIME 1.5GM (VIAL)
12/13/2025
12/13/2025
IV
1.5g
PTOR
Elective Cs
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: